In rheumatic diseases, OX40/OX40L signaling contributes to chronic inflammation and immune dysregulation—the hallmark features of conditions, such as RA, SLE, and other autoimmune disorders [53,54]. This evidence concerns the gene TNFRSF4 and systemic lupus erythematosus.